v3.21.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Federal grants $ 1,200,816 $ 827,639 $ 1,895,907 $ 3,514,720
Operating expenses:        
Research and development 1,714,635 892,991 2,502,232 3,136,207
General and administrative 16,372,976 339,422 17,257,361 898,470
Total operating expenses 18,087,611 1,232,413 19,759,593 4,034,677
Loss from operations (16,886,795) (404,774) (17,863,686) (519,957)
Other income (expense):        
Adjustment to initial fair value of debt (1,325,804) (1,325,804)
Issuance costs for convertible notes (500,158) (500,158)
Change in fair value of liabilities 1,476,185 2,171,446 2,149,499 1,088,272
Interest expense (24,660) (216,166) (1,282,820) (747,530)
Loss on extinguishment of debt (347,566)
Other income and expense, net 61,758 61,758
Total other income (expense), net (312,679) 1,955,280 (1,245,091) 340,742
Net income (loss) (17,199,474) 1,550,506 (19,108,777) (179,215)
Net loss attributable to noncontrolling interests (35,948) (20,014) (61,976) (21,990)
Net income (loss) attributable to common stockholders $ (17,163,526) $ 1,570,520 $ (19,046,801) $ (157,225)
Net income (loss) per basic share:        
Net income (loss) per share attributable to common stockholders, basic $ (0.71) $ 0.10 $ (1.02) $ (0.01)
Weighted average common shares outstanding, basic 24,255,786 15,768,725 18,755,252 15,768,725
Net income (loss) per diluted share:        
Net income (loss) per share attributable to common stockholders, diluted $ (0.71) $ 0.09 $ (1.02) $ (0.01)
Weighted average common shares outstanding, diluted 24,255,786 16,849,422 18,755,252 15,768,725

Source